A detailed history of Canada Pension Plan Investment Board transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 59,600 shares of CPRX stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,600
Holding current value
$1.29 Million
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$19.73 - $23.93 $1.18 Million - $1.43 Million
59,600 New
59,600 $1.24 Million
Q4 2022

Feb 14, 2023

BUY
$12.25 - $19.5 $659,050 - $1.05 Million
53,800 New
53,800 $1 Million

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.